क्यूआर कोड

Evaluation of atezolizumab immunogenicity: Clinical pharmacology (part 1)

Abstract Baseline patient characteristics and prognostic factors are important considerations in oncology when evaluating the impact of immunogenicity on pharmacokinetics (PK) and efficacy. Here, we assessed the impact of anti‐drug antibodies (ADA) on the PK of the immune checkpoint inhibitor atezol...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Benjamin Wu, Nitzan Sternheim, Priya Agarwal, Julia Suchomel, Shweta Vadhavkar, Rene Bruno, Marcus Ballinger, Coen A. Bernaards, Phyllis Chan, Jane Ruppel, Jin Jin, Sandhya Girish, Amita Joshi, Valerie Quarmby
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Wiley 2022-01-01
श्रृंखला:Clinical and Translational Science
ऑनलाइन पहुंच:https://doi.org/10.1111/cts.13127
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन